FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209939069> ?p ?o ?g. }

• W3209939069 endingPage "102986" @default.
• W3209939069 startingPage "102986" @default.
• W3209939069 abstract "The Coronavirus Disease 2019 (COVID-19) pandemic influenced the management of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. A paucity of data exists on outcome of patients with vasculitis following COVID-19, but mortality is higher than in the general population and comparable to patients undergoing haemodialysis or kidney transplant recipients (reported mortality rates of 20-25%). Delays in diagnosis have been reported, which are associated with sequelae such as dialysis-dependency. Management of ANCA-associated vasculitis has not changed with the aim to suppress disease activity and reduce burden of disease. The use of rituximab, an important and widely used agent, is associated with a more severe hospital course of COVID-19 and absence of antibodies following severe acute respiratory syndrome (SARS)-CoV-2 infections, which prone patients to re-infection. Reports on vaccine antibody response are scarce at the moment, but preliminary findings point towards an impaired immune response, especially when patients receive rituximab as part of their treatment. Seropositivity was reported in less than 20% of patients when rituximab was administered within the prior six months, and the antibody response correlated with CD19+ B-cell repopulation. A delay in maintenance doses, if disease activity allows, has been suggested using a CD19+ B-cell guided strategy. Other immunosuppressive measures, which are used in ANCA-associated vasculitis, also impair humoral and cellular vaccine responses. Regular measurements of vaccine response or a healthcare-policy time-based strategy are indicated to provide additional doses (booster) of COVID-19 vaccines. This review summarizes a recent educational forum and a recent virtual meeting of the European Vasculitis Society (EUVAS) focusing on COVID-19." @default.
• W3209939069 created "2021-11-08" @default.
• W3209939069 creator A5006333624 @default.
• W3209939069 creator A5015537437 @default.
• W3209939069 creator A5046434174 @default.
• W3209939069 creator A5046566613 @default.
• W3209939069 creator A5058786394 @default.
• W3209939069 creator A5059764745 @default.
• W3209939069 creator A5069826829 @default.
• W3209939069 creator A5070674274 @default.
• W3209939069 creator A5071542747 @default.
• W3209939069 creator A5076271217 @default.
• W3209939069 creator A5077186159 @default.
• W3209939069 date "2021-12-01" @default.
• W3209939069 modified "2023-10-06" @default.
• W3209939069 title "The COVID-19 pandemic and ANCA-associated vasculitis – reports from the EUVAS meeting and EUVAS education forum" @default.
• W3209939069 cites W1545589558 @default.
• W3209939069 cites W1752938210 @default.
• W3209939069 cites W2019752869 @default.
• W3209939069 cites W2088365057 @default.
• W3209939069 cites W2101360897 @default.
• W3209939069 cites W2125291401 @default.
• W3209939069 cites W2127847625 @default.
• W3209939069 cites W2128317151 @default.
• W3209939069 cites W2158971557 @default.
• W3209939069 cites W2607382700 @default.
• W3209939069 cites W2922148206 @default.
• W3209939069 cites W2981844738 @default.
• W3209939069 cites W3016393661 @default.
• W3209939069 cites W3025319121 @default.
• W3209939069 cites W3028556980 @default.
• W3209939069 cites W3031234495 @default.
• W3209939069 cites W3035462977 @default.
• W3209939069 cites W3036101703 @default.
• W3209939069 cites W3044193368 @default.
• W3209939069 cites W3045184294 @default.
• W3209939069 cites W3045715678 @default.
• W3209939069 cites W3048259608 @default.
• W3209939069 cites W3057236025 @default.
• W3209939069 cites W3071465894 @default.
• W3209939069 cites W3081791594 @default.
• W3209939069 cites W3088243710 @default.
• W3209939069 cites W3090973892 @default.
• W3209939069 cites W3092474480 @default.
• W3209939069 cites W3095024243 @default.
• W3209939069 cites W3096975836 @default.
• W3209939069 cites W3104666440 @default.
• W3209939069 cites W3106603320 @default.
• W3209939069 cites W3108411523 @default.
• W3209939069 cites W3111013777 @default.
• W3209939069 cites W3113547170 @default.
• W3209939069 cites W3114478940 @default.
• W3209939069 cites W3118763726 @default.
• W3209939069 cites W3123296893 @default.
• W3209939069 cites W3124810175 @default.
• W3209939069 cites W3124950897 @default.
• W3209939069 cites W3128038244 @default.
• W3209939069 cites W3128389767 @default.
• W3209939069 cites W3128634823 @default.
• W3209939069 cites W3129564206 @default.
• W3209939069 cites W3129951990 @default.
• W3209939069 cites W3132522233 @default.
• W3209939069 cites W3132728920 @default.
• W3209939069 cites W3133769791 @default.
• W3209939069 cites W3137721257 @default.
• W3209939069 cites W3138068799 @default.
• W3209939069 cites W3138515174 @default.
• W3209939069 cites W3148196185 @default.
• W3209939069 cites W3153043776 @default.
• W3209939069 cites W3153646335 @default.
• W3209939069 cites W3157705224 @default.
• W3209939069 cites W3159265369 @default.
• W3209939069 cites W3162142758 @default.
• W3209939069 cites W3163785571 @default.
• W3209939069 cites W3164069651 @default.
• W3209939069 cites W3165768605 @default.
• W3209939069 cites W3166013862 @default.
• W3209939069 cites W3168984666 @default.
• W3209939069 cites W3170606898 @default.
• W3209939069 cites W3173109173 @default.
• W3209939069 cites W3175761506 @default.
• W3209939069 cites W3175995708 @default.
• W3209939069 cites W3176897911 @default.
• W3209939069 cites W3177237905 @default.
• W3209939069 cites W3177299604 @default.
• W3209939069 cites W3177852708 @default.
• W3209939069 cites W3180256422 @default.
• W3209939069 cites W3182350146 @default.
• W3209939069 cites W3183100612 @default.
• W3209939069 cites W3189028477 @default.
• W3209939069 cites W3193131101 @default.
• W3209939069 cites W3197081215 @default.
• W3209939069 cites W4206609781 @default.
• W3209939069 cites W4210642183 @default.
• W3209939069 cites W4213073926 @default.
• W3209939069 doi "https://doi.org/10.1016/j.autrev.2021.102986" @default.
• W3209939069 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8552556" @default.
• W3209939069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34718165" @default.

• next